CN1192369A - Medicine for treating cirrhosis - Google Patents
Medicine for treating cirrhosis Download PDFInfo
- Publication number
- CN1192369A CN1192369A CN98105026A CN98105026A CN1192369A CN 1192369 A CN1192369 A CN 1192369A CN 98105026 A CN98105026 A CN 98105026A CN 98105026 A CN98105026 A CN 98105026A CN 1192369 A CN1192369 A CN 1192369A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- medicine
- angelicae sinensis
- long
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of traditional Chinese medicine for treating liver cirrhosis, it consists of root of membranousmilk vetch, capillary artemisia, root of red-rooted salvia, unpeeled root of herbaceous peony, arrowhead etc. 19 traditional Chinese medicinal herbs and is made into concentrated pills or capsules or powder etc. Chinese proprietary medicine through the ordinary traditional Chinese medicinal prepn. method. Said medicine can prolong the survival rate of patients of cancer of liver and ascites due to liver cirrhosis about 3-10 years.
Description
The present invention relates to a kind of Chinese medicine medicine for the treatment of liver cirrhosis.
Cirrhosis is a common frdquently encountered disease clinically after the hepatitis, is to cause the principal element of sending out canceration of hepatic cell.At present, whole world pathogenesis of cirrhosis rate is 2.5~3.5%, there is every year the people more than 400,000 to die from portal hypertension syndrome (upper gastrointestinal hemorrhage and/or ascites), also accounts for more than 4.5% of internal medicine number of hospitalized, and be the trend that increases year by year at the sickness rate of China's liver cirrhosis.Now the treatment of primary disease still there is not breakthrough.Main medicine, as: inosine, glucuronolatone, albumin, cellular energy mixture, compound amino acid supplement etc., still unsatisfactory to the cure rate and the alleviation complication that improve liver cirrhosis, treatment to cirrhotic ascites is corrected measures such as water salt through bed, limit sodium, spironolactone, diuretic, albumin, success rate only is 60%, acts on of short duration.
Reflecting to do has the problem that exists in the Drug therapy liver cirrhosis now, the purpose of this invention is to provide the Chinese medicine medicine of a kind of antiviral and the interior fibrosis of inhibition liver, mediation microcirculation, enhancing body immunity, minimizing alleviation liver cirrhosis.
Chinese medicine medicine of the present invention is made up of 19 flavor Chinese medicines such as the Radix Astragali, ZANGYINCHEN, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Carapax Trionycis pearl, Rhizoma sagittariae sagittifoliae, OYSTER EXTRACT CAPSULE, Rhizoma Polygoni Cuspidati, Polyporus, long-pending reality, Rhizoma Cyperi, Radix Angelicae Sinensis, Radix Bupleuri, Semen Persicae, Colla Corii Asini, eupolyphaga, stir-fry Semen Pharbitidis, Radix Et Rhizoma Rhei (parched).
Pharmaceutical compositions of the present invention forms (weight ratio) scope: black ugly 1.8~2.7% rhubarb,torrefieds, 0.9~2.7% each the component summation of the Radix Astragali 5.3~16.0% Tibetan oriental wormwoods, 5.3~16.0% reds sage root 5.3~13.3% radix paeoniae rubrathe, 2.7~13.3% bighead atractylodes rhizomes 5.3~10.7% turtle shell pearls, 5.3~10.7% arrowheads 5.3~10.7% OYSTER EXTRACT CAPSULEs, 5.3~10.7% giant knotweeds 5.3~10.7% umbellate pore furgus, 2.7~5.3% long-pending real 2.7~5.3% rhizoma cyperis 2.7~5.3% Radix Angelicae Sinensis, 1.8~5.3% radix bupleuri 1.8~2.7% peach kernels, 1.8~2.7% donkey-hide gelatin 1.8~2.7% soil units, 1.8~2.7% stir-frys is 100%.
The optimal drug composition forms (weight ratio): black 2.0~2.5% rhubarb,torrefieds, 1.5~2.0% each the component summation of the Radix Astragali 8.6~12.6% Tibetan oriental wormwoods, 8.6~12.6% reds sage root 7.0~11.0% radix paeoniae rubrathe, 6.0~9.0% bighead atractylodes rhizomes 6.5~9.5% turtle shell pearls, 6.5~9.5% arrowheads 6.5~9.5% OYSTER EXTRACT CAPSULEs, 6.5~9.5% giant knotweeds 6.5~9.5% umbellate pore furgus, 3.5~4.5% long-pending real 3.5~4.5% rhizoma cyperis 3.5~4.5% Radix Angelicae Sinensis, 3.2~4.0% radix bupleuri 2.0~2.5% peach kernels, 2.0~2.5% donkey-hide gelatin 2.0~2.5% soil units, 2.0~2.5% stir-frys are 100%.
Use the prescription of drug component of the present invention, adopt common Chinese medicine processing method and preparation process, can be made into Chinese patent medicines such as concentrated pill, capsule and electuary.
Use medicine of the present invention to use clinically, give full play to the comprehensive function of each component of Chinese medicine medicine, on effect, demonstrate unique polytropism and indication widely, to improving and adjusting body's immunity and suppress liver inner cellulose hypertrophy, improve the circulation of liver inner blood, prevent hepatic necrosis, promote hepatocellular reparation and regeneration, make the liver and spleen retraction of enlargement, ascites is ended development and is eliminated, and has played good effect.Take through clinical 58 routine cirrhotic ascites patients, effective percentage to liver, splenomegaly is respectively 88.6% and 90.6%, in vain, globulin (A/G) ratio inversion rate is 92.8%, portal hypertension syndrome (upper gastrointestinal hemorrhage and/or ascites) effective percentage is 100%, it is fast to fall enzyme (GPT), can end pathological development effectively, improves General Symptoms, find that through the CT check this medicine has the distinguished service of stronger inhibition hepatoma carcinoma cell disintegrate fragmentation, so can be used for the treatment of hepatocarcinoma.Use this medicine, the survival rate of cirrhotic ascites and liver cancer patient was improved 3~10 years, life quality is obviously improved.
Embodiment: carrying out concentrated pill of the present invention when producing, its compound method is, each component drug is cleaned, and it is qualified all to concoct, and weighs by recipe ingredient and assorts; Crushing screening then; Through liquor (except that Carapax Trionycis pearl and Colla Corii Asini), leaching medicinal liquid; Add Carapax Trionycis pearl fine powder and donkey-hide gelatin fine powder again and mix, be condensed into ball, cold drying, polishing, it is stand-by to bottle.
Claims (2)
1, a kind of by the Radix Astragali, ZANGYINCHEN, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, the Rhizoma Atractylodis Macrocephalae, the Carapax Trionycis pearl, Rhizoma sagittariae sagittifoliae, OYSTER EXTRACT CAPSULE, Rhizoma Polygoni Cuspidati, Polyporus, long-pending real, Rhizoma Cyperi, Radix Angelicae Sinensis, Radix Bupleuri, Semen Persicae, Colla Corii Asini, eupolyphaga, fry the Chinese medicine medicine of the treatment liver cirrhosis of Semen Pharbitidis and Radix Et Rhizoma Rhei (parched) composition, it is characterized in that the component composition (weight ratio) of this medicine is: the summation that the Radix Astragali 5.3~16.0% ZANGYINCHEN 5.3~16.0% Radix Salviae Miltiorrhizaes 5.3~13.3% Radix Paeoniae Rubra 2.7~13.3% Rhizoma Atractylodis Macrocephalaes 5.3~10.7% Carapax Trionycis pearls 5.3~10.7% Rhizoma sagittariae sagittifoliaes 5.3~10.7% OYSTER EXTRACT CAPSULE 5.3~10.7% Rhizoma Polygoni Cuspidati 5.3~10.7% Polyporus 2.7~5.3% long-pending real 2.7~5.3% Rhizoma Cyperis, 2.7~5.3% Radix Angelicae Sinensis, 1.8~5.3% Radix Bupleuri, 1.8~2.7% Semen Persicaes, 1.8~2.7% Colla Corii Asini, 1.8~2.7% eupolyphaga 1.8~2.7% are fried Semen Pharbitidis 1.8~2.7% Radix Et Rhizoma Rhei (parched) 0.9~2.7% each component is 100%.
2, the Chinese medicine for the treatment of cirrhosis according to claim 1 is characterized in that this medicine contains (weight ratio): black ugly 2.0~2.5% rhubarb,torrefieds, 1.5~2.1% each the component summation of the Radix Astragali 8.6~12.6% Tibetan oriental wormwoods, 8.6~12.6% reds sage root 7.0~11.0% radix paeoniae rubrathe, 6.0~9.0% bighead atractylodes rhizomes 6.5~9.5% turtle shell pearls, 6.5~9.5% arrowheads 6.5~9.5% OYSTER EXTRACT CAPSULEs, 6.5~9.5% giant knotweeds 6.5~9.5% umbellate pore furgus, 3.5~4.5% long-pending real 3.5~4.5% rhizoma cyperis 3.5~4.5% Radix Angelicae Sinensis, 3.2~4.0% radix bupleuri 2.0~2.5% peach kernels, 2.0~2.5% donkey-hide gelatin 2.0~2.5% soil units, 2.0~2.5% stir-frys are 100%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98105026A CN1192369A (en) | 1998-01-25 | 1998-01-25 | Medicine for treating cirrhosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98105026A CN1192369A (en) | 1998-01-25 | 1998-01-25 | Medicine for treating cirrhosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1192369A true CN1192369A (en) | 1998-09-09 |
Family
ID=5218646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98105026A Pending CN1192369A (en) | 1998-01-25 | 1998-01-25 | Medicine for treating cirrhosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1192369A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100413518C (en) * | 2005-03-23 | 2008-08-27 | 刘朝辉 | Capsule for treating cirrhosis ascites and its preparation technology |
-
1998
- 1998-01-25 CN CN98105026A patent/CN1192369A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100413518C (en) * | 2005-03-23 | 2008-08-27 | 刘朝辉 | Capsule for treating cirrhosis ascites and its preparation technology |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100384467C (en) | Traditional Chinese medicine composition for treating hepatitis and fatty liver | |
CN102488850B (en) | Traditional Chinese medicinal composition for treating alcoholic fatty liver and preparation method thereof | |
CN102319407B (en) | Traditional Chinese medicine for treating gastroptosis and extraction method thereof | |
CN1194843A (en) | Method for producing green health medicine | |
CN102319408B (en) | Chinese medicine for strengthening spleen, eliminating dampness and treating gastroptosis and extraction method thereof | |
CN103301412A (en) | Traditional Chinese medicine composition for treating alcoholic liver | |
CN104083727A (en) | Traditional Chinese medicine composition for nourishing and protecting liver | |
WO2022227331A1 (en) | Composition for preventing rheumatoid arthritis, preparation method therefor, and application thereof | |
CN103977361A (en) | Traditional Chinese medicine for treating ascites caused by cirrhosis and preparation method thereof | |
CN102397372A (en) | Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome | |
CN101011562B (en) | Novel formulation of shenqiwendan decoction and production method thereof | |
CN101112591A (en) | Medicine for treating cirrhosis and production process thereof | |
CN108042766A (en) | A kind of Bushen Tongluo supports brain cream and preparation method thereof | |
CN102526230B (en) | Traditional Chinese composition for curing liver disease and preparation method, quality detection method and application thereof | |
CN102327572B (en) | Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof | |
CN104524159A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
CN104740521B (en) | Preparation method of Ganfule soft capsule | |
CN1422643A (en) | Oral pill for treating lupus erythematosus | |
CN104523873A (en) | Pharmaceutical composition for treating gout | |
CN1192369A (en) | Medicine for treating cirrhosis | |
CN101199697B (en) | Nourishing kidney expellant medicament | |
CN114699498A (en) | Pharmaceutical composition for resisting chronic hepatitis B and application thereof | |
CN104740520B (en) | Ganfule soft capsule and preparation method thereof | |
CN102058765A (en) | Chinese medicine preparation for treating cirrhosis and preparation method thereof | |
CN1814250B (en) | Chinese medicine composition for treating liver cirrhosis ascites and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |